I am a
Home I AM A Search Login

Papers of the Week

2020 Jul 12

Eur J Vasc Endovasc Surg

Optimal Pharmacological Treatment of Symptomatic Peripheral Arterial Occlusive Disease and Evidence of Female Patient Disadvantage: An Analysis of Health Insurance Claims Data.


Peters F, Kreutzburg T, Rieß HC, Heidemann F, Marschall U, L'hoest H, Debus ES, Sedrakyan A, Behrendt C-A
Eur J Vasc Endovasc Surg. 2020 Jul 12.
PMID: 32669223.


Optimal pharmacological treatment (OPT) for peripheral arterial occlusive disease (PAOD) includes prescription of lipid lowering drugs, antithrombotics, and antihypertensives to symptomatic patients affected by intermittent claudication or chronic limb threatening ischaemia. This study sought to determine sex disparities and time trends in prescription of OPT in this population (clinicaltrials.gov NCT03909022).